Description:
FAMILIAL ADENOMATOUS POLYPOSIS 1; FAP1
Repository
|
NIGMS Human Genetic Cell Repository
|
Subcollection |
Heritable Diseases Hereditary Cancers |
Class |
Heritable Cancer Syndromes and other Cancers |
Cell Type
|
Fibroblast
|
Transformant
|
Untransformed
|
Race
|
White
|
Family Member
|
10
|
Relation to Proband
|
son
|
Confirmation
|
Clinical summary/Case history
|
ISCN
|
46,XY
|
Species
|
Homo sapiens
|
Common Name
|
Human
|
Remarks
|
|
Passage Frozen |
3 |
|
IDENTIFICATION OF SPECIES OF ORIGIN |
Species of Origin Confirmed by Chromosome Analysis |
|
Gene |
APC |
Chromosomal Location |
5q21-q22 |
Allelic Variant 1 |
611731.0014; ADENOMATOUS POLYPOSIS COLI |
Identified Mutation |
GLN541TER; In a Dutch family with APC, Fodde et al. [Genomics 13: 1162-1168 (1992)] identified a CAG-to-TAG change in codon 541 converting glutamine to a stop codon. Hamilton et al. [New Eng. J. Med. 332: 839-847 (1995)] found the same mutation in a family with Turcot syndrome with medulloblastoma (their family 7). |
Remarks |
Polyps and cysts; see GM03955 Lymphoid; normal sensitivity to MNNG produced loss of colony-forming ability; 46,XY; donor subject has a C>T change at nucleotide 1621 in exon 12 of the APC gene (1621C>T) resulting in the conversion of a glutamine at codon 541 to a stop codon [Gln541Ter (Q541X)] |
Sommer CA1,2, Capilla A1,2, Molina-Estevez FJ1,2, Gianotti-Sommer A1,2, Skvir N2, Caballero I2, Chowdhury S1, Mostoslavsky G1,2., Modeling APC mutagenesis and familial adenomatous polyposis using human iPS cells PLoS One: 2018 |
PubMed ID: 30024920 |
Passage Frozen |
3 |
Split Ratio |
1:3 |
Temperature |
37 C |
Percent CO2 |
5% |
Medium |
Eagle's Minimum Essential Medium with Earle's salts and non-essential amino acids with 2mM L-glutamine or equivalent |
Serum |
15% fetal bovine serum Not inactivated |
Substrate |
None specified |
Subcultivation Method |
trypsin-EDTA |
Supplement |
- |
|
|